Key TakeawaysInspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates.The sleep apnea device maker expects second quarter sales to be 30% higher than a year ago.Inspire sees full-year revenue higher by 26% to 28% from 2023. Inspire Medical Systems (INSP) shares rose Monday after the maker of an implanted device to treat sleep apnea released preliminary results and updated guidance that beat forecasts. The company said it expects to report ...